REPL vs TSHA: stock comparison and AI forecast
Replimune Group, Inc. (REPL) and Taysha Gene Therapies, Inc. (TSHA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
REPL Replimune Group, Inc.
- Market Cap
- $1.66B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
TSHA Taysha Gene Therapies, Inc.
- Price
- $4.00 -39.8% · 6M
- Market Cap
- $1.30B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- REPL is 1.3 times larger than TSHA by market capitalization ($1.66B against $1.30B).
- REPL carries 0.83 times debt per unit of equity, against 0.21 times for TSHA.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | REPL | TSHA |
|---|---|---|
| Market Cap | $1.66B | $1.30B |
| P/B Ratio | 8.10x | 3.37x |
| EPS | $-3.02 | $-0.38 |
| Book Value/Share | $2.17 | $1.19 |
| Revenue/Share | – | $0.02 |
| FCF/Share | $-2.58 | $-0.41 |
Profitability & Margins
| Metric | REPL | TSHA |
|---|---|---|
| ROE | -132.4% | -38.6% |
| ROA | -72.5% | -31.8% |
| ROIC | -82.1% | -34.5% |
| Operating Margin | – | -2792.3% |
| Net Margin | – | -2728.0% |
| EBT Margin | – | -2792.3% |
| Tax Rate | 0.2% | 0.0% |
Financial Health
| Metric | REPL | TSHA |
|---|---|---|
| Current Ratio | 7.11x | 17.76x |
| Quick Ratio | 6.90x | – |
| D/E Ratio | 0.83x | 0.21x |
| Financial Leverage | 1.83x | 1.21x |
| Interest Coverage | -22.3x | -32.8x |
| Working Capital | $278M | $435M |
Cash Flow
| Metric | REPL | TSHA |
|---|---|---|
| Operating Cash Flow | -$246M | -$132M |
| Free Cash Flow | -$243M | -$133M |
| Capital Spending | $3M | -$380K |
| FCF/Sales | – | -2417.0% |
| CapEx/Sales | – | 7.0% |
Operational Efficiency
| Metric | REPL | TSHA |
|---|---|---|
| Asset Turnover | – | 0.01x |
| Fixed Assets Turnover | – | 2.3x |
Income Statement
| Metric | REPL | TSHA |
|---|---|---|
| Total Revenue | – | $5M |
| Operating Income | -$270M | -$153M |
| Net Income | -$271M | -$150M |
| R&D Expense | $189M | $123M |
Dividend & Shareholder Information
| Metric | REPL | TSHA |
|---|---|---|
| Shares Outstanding | 94M | 326M |
REPL vs TSHA: stock comparison and AI forecast
Which is bigger, REPL or TSHA?
REPL is 1.3 times larger than TSHA by market capitalization ($1.66B against $1.30B).
Which one does Intratio's AI model rank higher, REPL or TSHA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.